Entrada Therapeutics

About:

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

Website: https://www.entradatx.com

Top Investors: Wellington Management, MRL Ventures Fund, Point72 Ventures, Goldman Sachs, Janus Henderson Investors

Description:

Entrada Therapeutics’ mission is to treat devastating diseases through the intracellular delivery of biologics. Entrada’s technology enables the efficient intracellular delivery of proteins, peptides and nucleic acids, thus allowing for the development of programs across several intracellular target classes. The Company's novel approach addresses current challenges associated with both large and small molecule therapeutics and represents a fundamental advancement in the delivery of molecules into the cytosol. For more information, please visit www.entradatx.com.